Air India Caps Fares as Govt Acts on Soaring Ticket Prices
Air India caps domestic economy fares after government directive. Action follows IndiGo flight cancellations and skyrocketing airfares. Details inside.
Category : Search result: Eli Lilly trillion dollar market cap
Rupee rises to 89.69 vs dollar before RBI policy
Indian rupee strengthens by 20 paise against US dollar, trading at 89.69. Forex traders cautious ahead of RBI monetary policy announcement. Key details on market sentiment and outlook.
UP to buy back idle industrial land to boost manufacturing
Uttar Pradesh government plans a buy-back policy for unused industrial plots to unlock land, attract new units, and accelerate its $1 trillion economy goal. Minister Nandi directs zero-error execution.
Why Indian Companies With ₹5 Trillion Cash Are Cautious
Indian corporations are sitting on a massive ₹5 trillion cash reserve but remain hesitant to invest in expansion. Discover the key economic and global factors behind this cautious strategy.
Eli Lilly Slashes Zepbound Price in Obesity Drug Battle
Eli Lilly reduces Zepbound's starting price to $299 monthly, intensifying its price war with Novo Nordisk's Ozempic and Wegovy. New discounts aim to expand access to blockbuster weight-loss drugs.
Oral GLP-1 Pill Orforglipron Shows Weight Loss Success
Eli Lilly's oral GLP-1 drug Orforglipron offers needle-free weight management with significant results in Phase 3 trials. Discover how this tablet alternative works.
Lilly Singh: Women Aren't Funny? That's Dumb!
Exclusive interview with Lilly Singh on sisterhood, digital creators' respect, Hollywood diversity struggles, and why women comedians face unfair criticism. Read her powerful insights!
Indian Economy to Hit $4 Trillion with 7% Growth
India's economy is projected to grow at 7% or higher this fiscal year, crossing the $4 trillion milestone. CEA Nageswaran cites strong GDP performance and sectoral momentum.
Oral Weight-Loss Pill Orforglipron: Ozempic 2.0
Eli Lilly's daily pill orforglipron shows 12% weight loss in trials, potentially revolutionizing obesity treatment. Could this be the end of injections?
India GDP May Exceed 7%, Reach $4 Trillion by FY26: CEA
India's Chief Economic Adviser projects GDP growth above 7% in FY25, potentially reaching $4 trillion economy by FY26. Strong fundamentals drive economic momentum.
Oral Ozempic 2.0: Game-Changer Weight Loss Pills
Novo Nordisk and Eli Lilly develop daily oral weight loss pills with 10-16% average weight loss in trials. Pending FDA approval, these could replace injections.
Rupee falls 7 paise to 89.43 against US dollar
Indian rupee declined 7 paise to settle at 89.43 against US dollar amid weak equity markets and foreign fund outflows. Traders await key domestic macroeconomic data release.
India's Stock Market Liquidity Spreads Beyond Large-Caps
Market concentration hits multi-year lows as liquidity spreads across mid & small-caps. Discover how retail and institutional participation is reshaping India's equity landscape. Read more.
Dollar Index May Slide to 94 Before Late 2026 Rebound
Morgan Stanley forecasts US Dollar Index falling to 94 before rebounding in late 2026. Key drivers include US economic slowdown and policy changes. Read analysis.
Flexi-Cap Funds Attract ₹8,923 Crore as Flows Shift
Investors pivot to flexi-cap mutual funds as small and mid-cap valuations stretch. Net inflows jump 27% to ₹8,923 crore in October. Discover why flexibility is now the key strategy.
Dollar Falls on Fed Cut Hopes, NZ & Australia Currencies Gain
US dollar weakens as traders anticipate December Fed rate cut. New Zealand dollar surges after RBNZ policy shift, Australian inflation boosts Aussie. UK budget in focus.
Indian economy set to cross $4 trillion mark in FY26
Chief Economic Advisor V Anantha Nageswaran projects India's economy will surpass $4 trillion this fiscal year, emphasizing the need to align climate goals with economic growth.
India to Hit $4 Trillion Economy by FY26: CEA
India's economy projected to cross $4 trillion milestone by FY26, driven by strong growth fundamentals and macroeconomic stability. Learn what fuels this historic expansion.
Rupee rises 11 paise to 89.05 against US dollar
Indian rupee appreciated 11 paise to 89.05 against US dollar in early trade despite pressure from strong dollar and foreign capital outflows. Read latest forex market analysis.
Missouri QB Beau Pribula set for shock return vs Oklahoma
Missouri Tigers QB Beau Pribula is set to start against Oklahoma Sooners just four weeks after a dislocated ankle injury. Coach Drinkwitz confirms his availability for the pivotal road game.
Eli Lilly First Pharma to Reach $1 Trillion Market Cap
Eli Lilly makes pharmaceutical history as first company to achieve $1 trillion market capitalization after shares rose 1.7% on November 21, 2025. Learn what this means for investors.
Mid & Small Caps Beat Large Caps in Q2 Results
Mid and small cap companies delivered stronger Q2 results than large caps, with better revenue growth and operating performance. Discover which sectors led this impressive performance.
AMFI Data Shows Portfolio Diversification Drive Among Investors
Indian mutual fund investors are diversifying portfolios with flexi-cap and mid-cap funds, shifting from large-cap and small-cap investments. AMFI data reveals significant inflow changes and strong mid-cap fund performance.
UP's Push Toward $1 Trillion Economy Gains Momentum
Uttar Pradesh accelerates toward $1 trillion economy goal with rapid project implementation and policy reforms. Discover how the state is transforming its economic landscape.
Alzheimer's Drug Donanemab Approved in India
Eli Lilly's Alzheimer's drug donanemab gets Indian regulatory approval. The treatment slows cognitive decline by 35.1% and could be available next year. Learn about its benefits and pricing.
Alzheimer's Drug Donanemab Approved for India
Eli Lilly's Alzheimer's drug donanemab gets Indian regulator nod. The treatment slows cognitive decline by 35.1% and is expected to launch in India next year. Details on pricing and safety.
Novo Nordisk Cuts Wegovy Price, Eyes Oral Pill Launch
Novo Nordisk reduces Wegovy's price to $349 and prepares an aggressive launch for its oral weight-loss pill to combat competition from Eli Lilly and expand patient access.
Silicon Valley's $1 Trillion Unicorn Quest Reshapes VC
Silicon Valley VCs chase first $1 trillion unicorn as AI boom transforms investment strategies. Learn how Nvidia's $4 trillion success fuels this high-stakes race.
ICICI Prudential AMC Expert: India's Economy Sound
Anish Tawakley of ICICI Prudential AMC states India's macro setup is strong. Demand softness is a cyclical challenge. He shares views on earnings, trade deals, and preferred sectors. Read more for expert investment insights.
Cobra Kai: Is Hawk's Back Tattoo Real? Actor Reveals Truth
Cobra Kai's Jacob Bertrand reveals if his character Hawk's iconic back tattoo is real. Discover the show's fashion impact and fan reactions. Read more!
Page 1 of 4